COMPOSITIONS AND METHODS OF USE FOR THERAPEUTIC ANTIBODIES

The present invention relates to antibodies that specifically bind to IL12R 1, the non-signal transducing chain of the heterodimeric IL12 receptor (together with IL12R 2 chain) as well as IL23 receptor (together with IL23Rα chain). The invention more specifically relates to specific antibodies that...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: DELLA DUCATA DANIELA, CARBALLIDO HERRERA JOSE M, BARDROFF MICHAEL, HEUSSER CHRISTOPH, JAEGER UTE, SCHWAERZLER CHRISTOPH
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator DELLA DUCATA DANIELA
CARBALLIDO HERRERA JOSE M
BARDROFF MICHAEL
HEUSSER CHRISTOPH
JAEGER UTE
SCHWAERZLER CHRISTOPH
description The present invention relates to antibodies that specifically bind to IL12R 1, the non-signal transducing chain of the heterodimeric IL12 receptor (together with IL12R 2 chain) as well as IL23 receptor (together with IL23Rα chain). The invention more specifically relates to specific antibodies that are IL12 and IL23 receptor antagonists capable of inhibiting IL12/IL18 induced IFNγ production of T cells and compositions and methods of use for said antibodies to treat pathological disorders that can be treated by inhibiting IFNγ production, such as rheumatoid arthritis, psoriasis or inflammatory bowel diseases or other autoimmune and inflammatory disorders.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2012034231A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2012034231A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2012034231A13</originalsourceid><addsrcrecordid>eNrjZLBy9vcN8A_2DPH09wtWcPRzUfB1DfHwdwlW8HdTCA12VXDzD1II8XANcgxwDQ3xdAYqCfF08nfxdA3mYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXxocFGBoZGBsYmRsaGjobGxKkCAGM3KfA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>COMPOSITIONS AND METHODS OF USE FOR THERAPEUTIC ANTIBODIES</title><source>esp@cenet</source><creator>DELLA DUCATA DANIELA ; CARBALLIDO HERRERA JOSE M ; BARDROFF MICHAEL ; HEUSSER CHRISTOPH ; JAEGER UTE ; SCHWAERZLER CHRISTOPH</creator><creatorcontrib>DELLA DUCATA DANIELA ; CARBALLIDO HERRERA JOSE M ; BARDROFF MICHAEL ; HEUSSER CHRISTOPH ; JAEGER UTE ; SCHWAERZLER CHRISTOPH</creatorcontrib><description>The present invention relates to antibodies that specifically bind to IL12R 1, the non-signal transducing chain of the heterodimeric IL12 receptor (together with IL12R 2 chain) as well as IL23 receptor (together with IL23Rα chain). The invention more specifically relates to specific antibodies that are IL12 and IL23 receptor antagonists capable of inhibiting IL12/IL18 induced IFNγ production of T cells and compositions and methods of use for said antibodies to treat pathological disorders that can be treated by inhibiting IFNγ production, such as rheumatoid arthritis, psoriasis or inflammatory bowel diseases or other autoimmune and inflammatory disorders.</description><language>eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2012</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20120209&amp;DB=EPODOC&amp;CC=US&amp;NR=2012034231A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20120209&amp;DB=EPODOC&amp;CC=US&amp;NR=2012034231A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DELLA DUCATA DANIELA</creatorcontrib><creatorcontrib>CARBALLIDO HERRERA JOSE M</creatorcontrib><creatorcontrib>BARDROFF MICHAEL</creatorcontrib><creatorcontrib>HEUSSER CHRISTOPH</creatorcontrib><creatorcontrib>JAEGER UTE</creatorcontrib><creatorcontrib>SCHWAERZLER CHRISTOPH</creatorcontrib><title>COMPOSITIONS AND METHODS OF USE FOR THERAPEUTIC ANTIBODIES</title><description>The present invention relates to antibodies that specifically bind to IL12R 1, the non-signal transducing chain of the heterodimeric IL12 receptor (together with IL12R 2 chain) as well as IL23 receptor (together with IL23Rα chain). The invention more specifically relates to specific antibodies that are IL12 and IL23 receptor antagonists capable of inhibiting IL12/IL18 induced IFNγ production of T cells and compositions and methods of use for said antibodies to treat pathological disorders that can be treated by inhibiting IFNγ production, such as rheumatoid arthritis, psoriasis or inflammatory bowel diseases or other autoimmune and inflammatory disorders.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2012</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLBy9vcN8A_2DPH09wtWcPRzUfB1DfHwdwlW8HdTCA12VXDzD1II8XANcgxwDQ3xdAYqCfF08nfxdA3mYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXxocFGBoZGBsYmRsaGjobGxKkCAGM3KfA</recordid><startdate>20120209</startdate><enddate>20120209</enddate><creator>DELLA DUCATA DANIELA</creator><creator>CARBALLIDO HERRERA JOSE M</creator><creator>BARDROFF MICHAEL</creator><creator>HEUSSER CHRISTOPH</creator><creator>JAEGER UTE</creator><creator>SCHWAERZLER CHRISTOPH</creator><scope>EVB</scope></search><sort><creationdate>20120209</creationdate><title>COMPOSITIONS AND METHODS OF USE FOR THERAPEUTIC ANTIBODIES</title><author>DELLA DUCATA DANIELA ; CARBALLIDO HERRERA JOSE M ; BARDROFF MICHAEL ; HEUSSER CHRISTOPH ; JAEGER UTE ; SCHWAERZLER CHRISTOPH</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2012034231A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2012</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>DELLA DUCATA DANIELA</creatorcontrib><creatorcontrib>CARBALLIDO HERRERA JOSE M</creatorcontrib><creatorcontrib>BARDROFF MICHAEL</creatorcontrib><creatorcontrib>HEUSSER CHRISTOPH</creatorcontrib><creatorcontrib>JAEGER UTE</creatorcontrib><creatorcontrib>SCHWAERZLER CHRISTOPH</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DELLA DUCATA DANIELA</au><au>CARBALLIDO HERRERA JOSE M</au><au>BARDROFF MICHAEL</au><au>HEUSSER CHRISTOPH</au><au>JAEGER UTE</au><au>SCHWAERZLER CHRISTOPH</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>COMPOSITIONS AND METHODS OF USE FOR THERAPEUTIC ANTIBODIES</title><date>2012-02-09</date><risdate>2012</risdate><abstract>The present invention relates to antibodies that specifically bind to IL12R 1, the non-signal transducing chain of the heterodimeric IL12 receptor (together with IL12R 2 chain) as well as IL23 receptor (together with IL23Rα chain). The invention more specifically relates to specific antibodies that are IL12 and IL23 receptor antagonists capable of inhibiting IL12/IL18 induced IFNγ production of T cells and compositions and methods of use for said antibodies to treat pathological disorders that can be treated by inhibiting IFNγ production, such as rheumatoid arthritis, psoriasis or inflammatory bowel diseases or other autoimmune and inflammatory disorders.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US2012034231A1
source esp@cenet
subjects BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
title COMPOSITIONS AND METHODS OF USE FOR THERAPEUTIC ANTIBODIES
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T11%3A41%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DELLA%20DUCATA%20DANIELA&rft.date=2012-02-09&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2012034231A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true